explore -WSS

explore

author：hotspot 2025-10-01 02:13:18 - browse：9

accountable care organizations cost saving — Adobe

WASHINGTON — A key Obama-era initiative was supposed to save Medicare money by testing new policies for cutting health care costs. It has so far failed to do so, according to nonpartisan congressional budget experts, and it’s not expected to save money anytime soon.

The 2010 Affordable Care Act created a government center, named the Center for Medicare and Medicaid Innovation, that was given $10 billion over a decade to test new Medicare and Medicaid pay policies. It has since been funded at the same level for another 10 years.

Republicans have attacked the center over the years. Although most of its pilot programs involve lowering hospital spending, some of the center’s initiatives aiming to lower spending on drugs have often provoked GOP ire. Most recently, they attacked the center’s proposal to cut Medicare pay for drugs that receive accelerated approvals. The Trump administration also used pilot programs to cut drug spending, including its failed attempt to tie Medicare drug payments to prices abroad.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： CDC advisory group OKs chikungunya vaccine

hotspot

WSS

Redefining sustainability for the pharmaceutical industry

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Using force crossed my mind when examining a defiant young patient

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

Kaiser's Risant Health gobbled up Geisinger. Who is next?

At ASCO, AstraZeneca reports strong data for breast cancer drug

entertainment

explore

knowledge

Activists slam private health insurers over coverage restrictions

NIH documents show early flaws of $1.6 billion long Covid program

State Dept. review finds Biden bears some blame for Afghanistan failures

See how much Covid

Tori Bowie and the unacceptable rates of Black maternal death

Using force crossed my mind when examining a defiant young patient

Psychedelics group wrestles with new pharma identity

Innovation in antibiotics is ailing. 'Brain drain' may kill it

How to save PrEP access — and even expand it

Redefining sustainability for the pharmaceutical industry

hotspot

FDA's Pazdur wants cancer trials to range beyond China alone

Readout Newsletter: Beam, Prozac, "TechBio" and more

Change Healthcare cyberattack shows risk of industry consolidation

Children’s Hospital revives plan for pedestrian bridge

CDC panel: People 65 and older should get a Covid spring booster shot

With trial win, GSK could get blood cancer drug back on market

hotspot

leisure time

focus

hotspot